BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-09-30
• Last 15 days FTD volume: $0.41 M
• Last 3 months FTD volume: $0.69 M
• Last 12 months FTD volume: $9.12 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	$4.82 M	$77.07 M	🇺🇸 USA
GSK plc GSK	$15.05 M	$0.15 B	🇬🇧 UK
Sarepta Therapeutics SRPT	$3.74 M	$23.35 M	🇺🇸 USA
Repligen RGEN	$22.62 M	$59.27 M	🇺🇸 USA
Novavax NVAX	$13.31 M	$56.18 M	🇺🇸 USA
Celldex Therapeutics CLDX	$3.28 M	$12.7 M	🇺🇸 USA
NanoViricides NNVC	$0.03 M	$2.6 M	🇺🇸 USA
Cel-Sci CVM	$0.05 M	$1.42 M	🇺🇸 USA
Emergent BioSolutions EBS	$0.6 M	$5.9 M	🇺🇸 USA